■住院咨询的平均疼痛强度,例如在癌症患者中,是已知的。然而,必要的咨询在病房或医院患者总量中的比例,手术室的一般疼痛强度和止痛药之间的关系,住院时间和治疗成功率未知。该研究的目的是检查单个正常病房中的手术患者,这些病房分为不同的组(-/手术,ICU停留,癌症,疼痛治疗咨询等。)在半年内关于他们的痛苦。为此,在整个住院期间,每天记录每位患者的疼痛评分(NAS),并在整个临床过程中评估变化.
■2017年,根据标准化程序,对大学医院(“三级中心”)普通普通病房的所有连续新入院病例进行了半年以上的监测。记录从入院到出院的疼痛严重程度(分别通过“数字评定量表”[NRS]“视觉模拟量表”[VAS]测量),以及住院时间和服用的药物。患者组被细分为手术,重症监护室,癌症和疼痛咨询。算法分为两部分(第1部分,退烧药和吡硝胺;第2部分,WHO计划和精神药物),这是在几年前外科医生和疼痛治疗师之间定义的,被追求,因此被用作评估治疗成功的基础。
■269名患者被纳入研究。所有患者入院时的平均疼痛强度为VAS2.2。大多数群体(非癌症,重症监护病房[ICU],非ICU,手术干预(=手术[OP]),非OP,大于VAS3)的疼痛强度显着降低了出院时的疼痛。在这种情况下的一个例外是癌症相关疼痛的患者,因此,开始疼痛咨询。
■由于四分之三的会诊患者也报告癌症疼痛,这可能是在咨询和癌症组缺乏成功的治疗与这些患者的癌症有关.然而,可以证明,成功治疗组(无ICU疗程)的平均住院时间为4.2±3.9至8.4±8.1天(d),而两个未成功治疗的组经历了更长时间的停留(意味着“癌症”,11.1±9.4d;表示“咨询”,14.2±10.3d)。21名会诊患者,它原本是为了改善疼痛强度,尽管进行了适应性治疗,但仍无法成功治疗-这可以被认为是患者数量少的结果。由于会诊患者是唯一接受算法第2部分治疗的患者组,可以得出结论,该算法的第1部分是足够的平均停留时间长达9天。对于超过这个时间点的所有患者,应考虑适应医学治疗的疼痛咨询。
UNASSIGNED: The mean pain intensity for inpatient consultations, for example in cancer patients, is known. However, the proportion of necessary consultations in the total volume of patients of a ward or a hospital, the general pain intensity in a surgical ward and the relationship between pain medication, length of stay and therapeutic success are unknown. The aim of the study was to examine surgical patients in a single normal ward subclassified into various groups (-/+ surgery, ICU stay, cancer, consultation for pain therapy etc.) during half a year with regard to their pain. For this purpose, the pain score (NAS) was recorded daily for each patient during the entire hospital stay and the change was assessed over the clinical course.
UNASSIGNED: In 2017, all consecutive new admissions to a normal ward of general surgery at a university hospital (\"tertiary center\") were monitored over half a year according to a standardized procedure. Pain severity (measured by the \"Numeric rating scale\" [NRS] respectively \"Visual analogue scale\" [VAS]) from admission to discharge was recorded, as well as the length of stay and the administered medication. Patient groups were sub-classified as surgery, intensive care unit, cancer and pain consultation. An algorithm in two parts (part 1, antipyretics and piritramide; part 2, WHO-scheme and psychotropic drugs), which was defined years before between surgeons and pain therapists, was pursued and consequently used as a basis for the evaluation of the therapeutic success.
UNASSIGNED: 269 patients were included in the study. The mean pain intensity of all patients at admission was VAS 2.2. Most of the groups (non-cancer, intensive care unit [ICU], non-ICU, surgical intervention (=Operation [OP]), non-OP, pain intensity greater than VAS 3) were significantly reduced in pain at discharge. An exception in this context was patients with cancer-associated pain and, thus, initiated pain consultation.
UNASSIGNED: Since three quarters of the consultation patients also reported cancer pain, it might be possible that the lack of treatment success in both the consultation and cancer groups is associated with cancer in these patients. However, it can be shown that the successfully treated groups (without ICU-based course) had a mean length of stay from 4.2 ± 3.9 up to 8.4 ± 8.1 days (d), while the two unsuccessfully treated groups experienced a longer stay (mean\"cancer\", 11.1 ± 9.4 d; mean\"consulation\", 14.2 ± 10.3 d). Twenty-one consultation patients, in whom it had been intended to improve pain intensity, could not be successfully treated despite adapted therapy - this can be considered a consequence of the low number of patients. Since the consultation patients were the only patient group treated with part 2 of the algorithm, it can be concluded that part 1 of the algorithm is sufficient for a mean length of stay up to 9 days. For all patients above this time point, a pain consultation with adaption of medical treatment should be considered.